HPV: diagnosis, prevention, and treatment

Area of Science:

• Infectious Diseases
• Oncology
• Public Health

Background:

• Human papilloma virus (HPV) is the most prevalent sexually transmitted infection globally.
• A significant portion of the population, approximately 80% by age 50, encounters HPV.
• HPV infection is a known precursor to several cancers, including oropharyngeal, genital, and anal cancers, as well as genital warts.

Purpose of the Study:

• To summarize the epidemiology and clinical implications of Human Papilloma Virus (HPV) infection.
• To highlight the burden of HPV-related diseases and the current prevention and treatment strategies.
• To underscore the importance of HPV vaccination and address barriers to its uptake.

Main Methods:

• Literature review of HPV epidemiology, pathogenesis, and clinical outcomes.
• Analysis of HPV-related cancer incidence and mortality data.
• Evaluation of current HPV treatment modalities and vaccine efficacy.

Main Results:

• HPV is the most common STD worldwide, with high lifetime exposure rates.
• Persistent HPV infections are a major risk factor for developing various malignancies.
• Available HPV vaccines are effective but face challenges with low global usage.

Conclusions:

• Effective vaccines exist to prevent infection by common HPV types, reducing cancer risk.
• Low vaccine uptake remains a significant public health concern.
• While most HPV infections resolve spontaneously, persistent cases necessitate vigilant monitoring and management of lesions.